ORGANOGENESIS HOLDINGS INC. Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions of 100.00% for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Notes › Equity
us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions · last filed 2018-11-09
- ORGANOGENESIS HOLDINGS INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for the quarter ending 2018-03-31 was 100.00%.
- ORGANOGENESIS HOLDINGS INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for fiscal 2017 was 100.00%.
| Period end | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 3 month | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 6 month | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 9 month | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 12 month |
|---|---|---|---|---|
| 2018-09-30 | 100.00% 10-Q · filed 2018-11-09 | |||
| 2018-06-30 | 100.00% 10-Q · filed 2018-08-07 | |||
| 2018-03-31 | 100.00% 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | 100.00% 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |